cytosine has been researched along with Adenocarcinoma in 31 studies
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In addition, mean residual tumor weights (expressed in grams) after 20-22 days were: Group 1, 12." | 5.30 | Bropirimine as neoadjuvant therapy decreases residual disease and expression of markers PCNA and TGF-beta 1 in a rat orthotopic prostate adenocarcinoma. ( Bridges, P; Brown, J; Di Domenico, D; Guinan, P; Lievano, G; Rubenstein, M; Shaw, M, 1997) |
| "The human pancreatic adenocarcinoma cell lines, AsPC-1, Capan-2, MIA PaCa-2 and Panc-1, were exposed to troxacitabine or gemcitabine alone or in combination, for 72 h, and the effects on cell growth were determined by electronic particle counting." | 3.74 | Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer. ( Bouffard, DY; Cass, CE; Clarke, ML; Damaraju, VL; Gourdeau, H; Grey, M; Leblond, L; Mackey, JR; Wong, CK, 2007) |
| "Under study was the nucleotide content and the level of methylated cytosine (5-MC) in the DNA, isolated from adenocarcinoma of the stomach, gastric mucosa in patients with duodenal ulcer as well as from the mucosa of intact human stomach." | 3.66 | [Nucleotide composition and the methylated cytosine level in the DNA from a cancerous stomach tumor]. ( Kliasheva, RI; Panfilova, GA; Volkov, VE, 1980) |
| " Our study suggests that inkjet printing technology can be utilized in the development of antiviral/anticancer combination dosage forms for mucosal application." | 1.46 | Inkjet printing of antiviral PCL nanoparticles and anticancer cyclodextrin inclusion complexes on bioadhesive film for cervical administration. ( Aktaş, Y; Bilensoy, E; Sandler, N; Varan, C; Wickström, H, 2017) |
| "Second, tumors occurring in homozygous carriers of the methionine synthase 2756G allele show a lower number of hypermethylated CpG islands of tumor suppressor genes (P = 0." | 1.31 | Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. ( Avila, S; Capella, G; Esteller, M; Fraga, MF; Herman, JG; Paz, MF; Peinado, MA; Pollan, M; Sanchez-Cespedes, M, 2002) |
| "In addition, mean residual tumor weights (expressed in grams) after 20-22 days were: Group 1, 12." | 1.30 | Bropirimine as neoadjuvant therapy decreases residual disease and expression of markers PCNA and TGF-beta 1 in a rat orthotopic prostate adenocarcinoma. ( Bridges, P; Brown, J; Di Domenico, D; Guinan, P; Lievano, G; Rubenstein, M; Shaw, M, 1997) |
| "A series of 214 cases with familial breast cancer were analysed using this approach; 88/214 were heterozygous for the promoter polymorphism, thereby excluding a deletion in this region." | 1.30 | Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions. ( Brown, MA; Catteau, A; Dunning, AM; Greenman, J; Hodgson, S; Mathew, CG; Solomon, E; Xu, CF, 1999) |
| "Established prostate cancer-derived cell lines LnCAP, DU-145, and PC-3 demonstrated NQO1 wild-type genotype." | 1.30 | 609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia. ( Borkowsi, M; Hillenbrand, M; Schuff-Werner, P; Seiter, H; Steiner, M, 1999) |
| " In the dosage used, TNF toxicity was mild, transient, and not influenced by ABPP." | 1.27 | Combined treatment of colon adenocarcinoma in rats with tumor necrosis factor and the interferon inducer ABPP. ( de Bruin, RW; Eggermont, AM; Fiers, W; Jeekel, J; Marquet, RL, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (12.90) | 18.7374 |
| 1990's | 11 (35.48) | 18.2507 |
| 2000's | 11 (35.48) | 29.6817 |
| 2010's | 4 (12.90) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmadi Hedayati, M | 1 |
| Ahmadi, A | 1 |
| Khatooni, Z | 1 |
| Varan, C | 1 |
| Wickström, H | 1 |
| Sandler, N | 1 |
| Aktaş, Y | 1 |
| Bilensoy, E | 1 |
| Kazlauskas, A | 1 |
| Darinskas, A | 1 |
| Meškys, R | 1 |
| Tamašauskas, A | 1 |
| Urbonavičius, J | 1 |
| Chapman, CG | 1 |
| Mariani, CJ | 1 |
| Wu, F | 1 |
| Meckel, K | 1 |
| Butun, F | 1 |
| Chuang, A | 1 |
| Madzo, J | 1 |
| Bissonnette, MB | 1 |
| Kwon, JH | 1 |
| Godley, LA | 1 |
| Tasca, G | 1 |
| Iorio, R | 1 |
| Basile, U | 1 |
| Lauriola, L | 1 |
| Tartaglione, R | 1 |
| Mirabella, M | 1 |
| Ricci, E | 1 |
| Sabatelli, M | 1 |
| Christensen, BC | 1 |
| Marsit, CJ | 1 |
| Houseman, EA | 1 |
| Godleski, JJ | 1 |
| Longacker, JL | 1 |
| Zheng, S | 1 |
| Yeh, RF | 1 |
| Wrensch, MR | 1 |
| Wiemels, JL | 1 |
| Karagas, MR | 1 |
| Bueno, R | 1 |
| Sugarbaker, DJ | 1 |
| Nelson, HH | 1 |
| Wiencke, JK | 1 |
| Kelsey, KT | 1 |
| Yan, L | 1 |
| Yanan, D | 1 |
| Donglan, S | 1 |
| Na, W | 1 |
| Rongmiao, Z | 1 |
| Zhifeng, C | 1 |
| Haffner, MC | 1 |
| Chaux, A | 1 |
| Meeker, AK | 1 |
| Esopi, DM | 1 |
| Gerber, J | 1 |
| Pellakuru, LG | 1 |
| Toubaji, A | 1 |
| Argani, P | 1 |
| Iacobuzio-Donahue, C | 1 |
| Nelson, WG | 1 |
| Netto, GJ | 1 |
| De Marzo, AM | 1 |
| Yegnasubramanian, S | 1 |
| Paz, MF | 1 |
| Avila, S | 1 |
| Fraga, MF | 1 |
| Pollan, M | 1 |
| Capella, G | 1 |
| Peinado, MA | 1 |
| Sanchez-Cespedes, M | 1 |
| Herman, JG | 1 |
| Esteller, M | 1 |
| Speina, E | 1 |
| Zielińska, M | 1 |
| Barbin, A | 1 |
| Gackowski, D | 1 |
| Kowalewski, J | 1 |
| Graziewicz, MA | 1 |
| Siedlecki, JA | 1 |
| Oliński, R | 1 |
| Tudek, B | 1 |
| Pang, RT | 1 |
| Lee, LT | 1 |
| Ng, SS | 1 |
| Yung, WH | 1 |
| Chow, BK | 1 |
| Gekeler, V | 1 |
| Gimmnich, P | 1 |
| Hofmann, HP | 1 |
| Grebe, C | 1 |
| Römmele, M | 1 |
| Leja, A | 1 |
| Baudler, M | 1 |
| Benimetskaya, L | 1 |
| Gonser, B | 1 |
| Pieles, U | 1 |
| Maier, T | 1 |
| Wagner, T | 1 |
| Sanders, K | 1 |
| Beck, JF | 1 |
| Hanauer, G | 1 |
| Stein, CA | 1 |
| Koyama, T | 1 |
| Nakamura, T | 1 |
| Komoto, C | 1 |
| Sakaeda, T | 1 |
| Taniguchi, M | 1 |
| Okamura, N | 1 |
| Tamura, T | 1 |
| Aoyama, N | 1 |
| Kamigaki, T | 1 |
| Kuroda, Y | 1 |
| Kasuga, M | 1 |
| Kadoyama, K | 1 |
| Okumura, K | 1 |
| Damaraju, VL | 1 |
| Bouffard, DY | 1 |
| Wong, CK | 1 |
| Clarke, ML | 1 |
| Mackey, JR | 1 |
| Leblond, L | 1 |
| Cass, CE | 1 |
| Grey, M | 1 |
| Gourdeau, H | 1 |
| Kliasheva, RI | 1 |
| Volkov, VE | 1 |
| Panfilova, GA | 1 |
| Sarosdy, MF | 1 |
| Higdon, AL | 1 |
| Demoor, CA | 1 |
| Mass, MJ | 1 |
| Wang, L | 2 |
| Lievano, G | 1 |
| Di Domenico, D | 1 |
| Brown, J | 1 |
| Bridges, P | 1 |
| Rubenstein, M | 1 |
| Shaw, M | 1 |
| Guinan, P | 1 |
| Guang, SG | 1 |
| Ogura, T | 1 |
| Sekine, I | 1 |
| Yokozaki, M | 1 |
| Esumi, H | 1 |
| Kodama, T | 1 |
| Nagai, K | 1 |
| Côté, S | 1 |
| Sinnett, D | 1 |
| Momparler, RL | 1 |
| Catteau, A | 1 |
| Xu, CF | 1 |
| Brown, MA | 1 |
| Hodgson, S | 1 |
| Greenman, J | 1 |
| Mathew, CG | 1 |
| Dunning, AM | 1 |
| Solomon, E | 1 |
| Steiner, M | 1 |
| Hillenbrand, M | 1 |
| Borkowsi, M | 1 |
| Seiter, H | 1 |
| Schuff-Werner, P | 1 |
| Toyota, M | 1 |
| Ho, C | 1 |
| Ahuja, N | 1 |
| Jair, KW | 1 |
| Li, Q | 1 |
| Ohe-Toyota, M | 1 |
| Baylin, SB | 1 |
| Issa, JP | 1 |
| Majeed, GS | 1 |
| Glew, S | 1 |
| Bidwell, J | 1 |
| Tsukuda, K | 1 |
| Tanino, M | 1 |
| Soga, H | 1 |
| Shimizu, N | 1 |
| Shimizu, K | 1 |
| Jubb, AM | 1 |
| Bell, SM | 1 |
| Quirke, P | 1 |
| Roh, MS | 1 |
| Kahky, MP | 1 |
| Oyedeji, C | 1 |
| Klostergaard, J | 1 |
| Curley, SA | 1 |
| Lotzová, E | 2 |
| McKay, PJ | 1 |
| Docherty, JG | 1 |
| la Ferla, G | 1 |
| Lucie, NP | 1 |
| Marquet, RL | 1 |
| Eggermont, AM | 1 |
| de Bruin, RW | 1 |
| Fiers, W | 1 |
| Jeekel, J | 1 |
| Savary, CA | 1 |
| Strong, LC | 1 |
| Matsunaga, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Indentifying Epigenetic Biomarkers From Peripheral Blood of Osteosarcoma Patients Based on hMe-Seal Technique[NCT03336554] | 100 participants (Anticipated) | Observational [Patient Registry] | 2017-09-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for cytosine and Adenocarcinoma
| Article | Year |
|---|---|
Methylation and colorectal cancer.
Topics: Adenocarcinoma; Adenoma; Aged; Aging; Biomarkers, Tumor; Chromatin; Colorectal Neoplasms; CpG Island | 2001 |
30 other studies available for cytosine and Adenocarcinoma
| Article | Year |
|---|---|
DNMT1 Gene Expression in Patients with
Topics: Adenocarcinoma; Antigens, Bacterial; Bacterial Proteins; Case-Control Studies; Cytosine; DNA, Comple | 2022 |
Inkjet printing of antiviral PCL nanoparticles and anticancer cyclodextrin inclusion complexes on bioadhesive film for cervical administration.
Topics: Adenocarcinoma; Administration, Intravaginal; Antiviral Agents; Cell Line, Tumor; Cervix Uteri; Cido | 2017 |
Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Brain Neoplasms; Caco-2 Cells; Cell Line, | 2019 |
TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer.
Topics: 5-Methylcytosine; Adenocarcinoma; Binding Sites; Cell Differentiation; Cell Line, Tumor; Colon; Colo | 2015 |
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia.
Topics: Adenocarcinoma; Agammaglobulinemia; Aged; Antiviral Agents; Brain; Brain Neoplasms; Cidofovir; Cytos | 2009 |
Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; CpG Islands; Cytosine; Diagnosis, Differential; DNA | 2009 |
Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Arginine; Cardia; Case-Control Studies; Codon; Cytosine; DNA R | 2009 |
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.
Topics: 5-Methylcytosine; Adenocarcinoma; Animals; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Differe | 2011 |
Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors.
Topics: 5-Methylcytosine; 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adenocarcinoma; Breast | 2002 |
Decreased repair activities of 1,N(6)-ethenoadenine and 3,N(4)-ethenocytosine in lung adenocarcinoma patients.
Topics: Adenine; Adenocarcinoma; Adult; Age Factors; Aged; Cytosine; DNA Adducts; DNA Repair; DNA, Neoplasm; | 2003 |
CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene.
Topics: Adenocarcinoma; Animals; Azacitidine; Base Composition; Base Sequence; Cattle; Cells, Cultured; CpG | 2004 |
G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Antineoplastic Agents; B-Lymphocytes; Carcinoma; Ce | 2006 |
MDR1 T-129C polymorphism can be predictive of differentiation, and thereby prognosis of colorectal adenocarcinomas in Japanese.
Topics: Adenocarcinoma; Cell Differentiation; Colorectal Neoplasms; Cytosine; DNA Primers; Gene Expression R | 2006 |
Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cytosine; Deoxycytidine; Di | 2007 |
[Nucleotide composition and the methylated cytosine level in the DNA from a cancerous stomach tumor].
Topics: 5-Methylcytosine; Adenocarcinoma; Base Composition; Cytosine; DNA, Neoplasm; Duodenal Ulcer; Gastric | 1980 |
In vivo antitumor activity of bropirimine against PAIII and Dunning MAT-LyLu rodent prostate cancers.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cytosine; Male; Neoplasm Transplantation; Prostatic | 1996 |
Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis.
Topics: Adenocarcinoma; Arsenic; Base Sequence; Carcinogens; Cytosine; DNA Methylation; Gene Expression Regu | 1997 |
Bropirimine as neoadjuvant therapy decreases residual disease and expression of markers PCNA and TGF-beta 1 in a rat orthotopic prostate adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biomarkers, Tumor; Cytosine; Down-Regulation; Gene E | 1997 |
Association between p53 mutation and clinicopathological features of non-small cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Analysis of Variance; Bas | 1997 |
Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells.
Topics: 5-Methylcytosine; Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Colon | 1998 |
Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions.
Topics: Adenocarcinoma; Adult; Age of Onset; Base Sequence; Breast Neoplasms; Cytosine; DNA; DNA, Neoplasm; | 1999 |
609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia.
Topics: Adenocarcinoma; Alleles; Cytosine; Female; Genes, Neoplasm; Genotype; Humans; Male; NAD(P)H Dehydrog | 1999 |
Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
Topics: 5-Methylcytosine; Adenocarcinoma; Chondroitin Sulfate Proteoglycans; Cloning, Molecular; Colorectal | 1999 |
An association between LSIL and the high secretor phenotype of IL-1beta.
Topics: Adenocarcinoma; Carcinoma in Situ; Carcinoma, Squamous Cell; Cytosine; Female; Humans; Interleukin-1 | 1999 |
A novel activating mutation of the K-ras gene in human primary colon adenocarcinoma.
Topics: 3T3 Cells; Adenine; Adenocarcinoma; Animals; Base Sequence; Cell Transformation, Neoplastic; Colonic | 2000 |
Murine Kupffer cells and hepatic natural killer cells regulate tumor growth in a quantitative model of colorectal liver metastases.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Cell Line; Cell Survival; Colonic Neo | 1992 |
Carcinoma of the small intestine following treated acute myeloid leukaemia.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytosine; Daunorubicin; Human | 1990 |
Combined treatment of colon adenocarcinoma in rats with tumor necrosis factor and the interferon inducer ABPP.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Cytosine; Drug Therapy, Combinati | 1988 |
Pyrimidinones: inducers of NK cell activity and antitumor immunity.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line; Cytosine; Female; Killer Cells, Natural; | 1986 |
Comparative effect of three nucleosides on suppression of cancer growth in mice.
Topics: Adenocarcinoma; Adenosine; Age Factors; Animals; Cytosine; Female; Injections, Intraperitoneal; Live | 1973 |